Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN)

CUSIP: 880881107

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
105,357,143
Total 13F shares
16,836,162
Share change
-383,589
Total reported value
$50,004,000
Price per share
$2.97
Number of holders
43
Value change
-$1,388,822
Number of buys
16
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 880881107?
CUSIP 880881107 identifies TERN - Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN) as of Q1 2022

As of 31 Mar 2022, Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN) was held by 43 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,836,162 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Vivo Capital, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), FMR LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, Antara Capital LP, BlackRock Inc., Decheng Capital Management III (Cayman), LLC, VANGUARD GROUP INC, and Samsara BioCapital, LLC. This page lists 43 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.